NUR3196 Test- Drugs| Questions and
100% Correct Verified Answers
Acetaminophen has no - Answer anti-inflammatory action and is not an NSAID therefore it
Hepatitis B Vaccine Therapeutic class - Answer vaccine
Hepatitis B Vaccine Pharmacologic class - Answer vaccine
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Actions and Uses - Answer -
recommended for infants and children younger than 19 (first dose at birth preferably),
healthcare workers or caregivers who at risk of contact with contaminated blood,
people with high risk sexual practices, people who share drug needles or other drug
injection equipment, people in correctional facilities, people with end stage renal
disease, chronic liver disease, HIV, or diabetes, and people who live or travel to
regions where Hepatitis B virus is common
- 99% to 100% effective at providing active immunity for patients. It is made
from recombinant DNA from yeast cells.
- Human blood is not used to make the vaccine
,Hepatitis B Vaccine doses - Answer - requires three doses
- second dose is given one month after the first dose
- third dose is given 6 months after the first dose
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Administration - Answer - delivered
intramuscularly into the deltoid muscle
- do not have a preservative so use promptly after single dose vial has been penetrated
- epinephrine (1:1000) for anaphylactic reaction
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Pregnancy category - Answer C
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Onset - Answer antibodies in 2 weeks
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Peak - Answer 6 months
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Duration - Answer 5 to 7 years
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Adverse Effects - Answer pain at
injection site, mild/moderate fever, chills, fatigue, dizziness, headache, anaphylaxis
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Contraindications - Answer -
hypersensitivity to yeast or the vaccine
- caution w/ pts w/ fever, active infection, or compromised cardiopulmonary status
- only use for pregnant/lactating people if needed for direct protection of parent or child
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Drug to drug interactions - Answer
immunosuppressants decrease effectiveness
,Interferon alfa-2b (Intron A) Therapeutic class - Answer Immunostimulant
Interferon alfa-2b (Intron A) Pharmacologic class - Answer Interferon, biologic
response modifier
Interferon alfa-2b (Intron A) Actions and Uses - Answer - approved to treat cancers
(hairy cell leukemia, malignant melanoma, non-Hodgkin lymphoma, A I D S-related
Kaposi sarcoma) as well as viral infections (human papillomavirus, chronic hepatitis virus
B and C)
- biologic response modifier prepared by recombinant DNA
- used for condylomata acuminata (genital warts) by being directly injected into
lesions 3x a week for 3 weeks
Interferon alfa-2b (Intron A) Administration - Answer -admin under guidance
of experienced provider
- subq admin recommended for pt at risk for bleeding (platelet count less than
50000/mm3)
Interferon alfa-2b (Intron A) Pregnancy category - Answer C
Interferon alfa-2b (Intron A) Onset - Answer 3 h (IM), immediate (IV)
Interferon alfa-2b (Intron A) Duration - Answer 2-3 h
Interferon alfa-2b (Intron A) Adverse Effects - Answer Flu-like syndrome of fever,
chills, dizziness, weight loss, and fatigue (occurs in at least 50% of patients)
Headache, nausea, vomiting, diarrhea, and anorexia
, Hair loss
Depression and suicidal ideation
Serious adverse effects (with prolonged therapy)
Immunosuppression
Hepatotoxicity
Neurotoxicity
Interferon alfa-2b (Intron A) Contraindications - Answer hypersensitivity to IFN
Autoimmune hepatitis or hepatic decompensation
Neonate or infant
Interferon alfa-2b (Intron A) Black box - Answer may cause or aggravate fatal or
life threatening neuropsychiatric, autoimmune, ischemic, or infectious disorders
Interferon alfa-2b (Intron A) Drug to drug interactions - Answer - use w/ ethanol may
cause excessive drowsiness/dehydration
- myelosuppression w/ antineoplastics
- zidovudine may increase hematologic toxicity
Interferon alfa-2b (Inton A) Lab test interactions - Answer - large decline in
hematocrit, leukocytes, platelets after 3-5 days of therapy
- elevated hepatic enzymes triglycerides
Interferon alfa-2b (Inton A) Treatment of overdose - Answer - causes lethargy/coma
- general supportive measures
Ibuprofen (Advil, Motrin) Therapeutic class - Answer analgesic, anti-inflammatory
drug, antipyretic
100% Correct Verified Answers
Acetaminophen has no - Answer anti-inflammatory action and is not an NSAID therefore it
Hepatitis B Vaccine Therapeutic class - Answer vaccine
Hepatitis B Vaccine Pharmacologic class - Answer vaccine
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Actions and Uses - Answer -
recommended for infants and children younger than 19 (first dose at birth preferably),
healthcare workers or caregivers who at risk of contact with contaminated blood,
people with high risk sexual practices, people who share drug needles or other drug
injection equipment, people in correctional facilities, people with end stage renal
disease, chronic liver disease, HIV, or diabetes, and people who live or travel to
regions where Hepatitis B virus is common
- 99% to 100% effective at providing active immunity for patients. It is made
from recombinant DNA from yeast cells.
- Human blood is not used to make the vaccine
,Hepatitis B Vaccine doses - Answer - requires three doses
- second dose is given one month after the first dose
- third dose is given 6 months after the first dose
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Administration - Answer - delivered
intramuscularly into the deltoid muscle
- do not have a preservative so use promptly after single dose vial has been penetrated
- epinephrine (1:1000) for anaphylactic reaction
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Pregnancy category - Answer C
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Onset - Answer antibodies in 2 weeks
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Peak - Answer 6 months
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Duration - Answer 5 to 7 years
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Adverse Effects - Answer pain at
injection site, mild/moderate fever, chills, fatigue, dizziness, headache, anaphylaxis
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Contraindications - Answer -
hypersensitivity to yeast or the vaccine
- caution w/ pts w/ fever, active infection, or compromised cardiopulmonary status
- only use for pregnant/lactating people if needed for direct protection of parent or child
Hepatitis B Vaccine (Engerix-B, Recombivax HB) Drug to drug interactions - Answer
immunosuppressants decrease effectiveness
,Interferon alfa-2b (Intron A) Therapeutic class - Answer Immunostimulant
Interferon alfa-2b (Intron A) Pharmacologic class - Answer Interferon, biologic
response modifier
Interferon alfa-2b (Intron A) Actions and Uses - Answer - approved to treat cancers
(hairy cell leukemia, malignant melanoma, non-Hodgkin lymphoma, A I D S-related
Kaposi sarcoma) as well as viral infections (human papillomavirus, chronic hepatitis virus
B and C)
- biologic response modifier prepared by recombinant DNA
- used for condylomata acuminata (genital warts) by being directly injected into
lesions 3x a week for 3 weeks
Interferon alfa-2b (Intron A) Administration - Answer -admin under guidance
of experienced provider
- subq admin recommended for pt at risk for bleeding (platelet count less than
50000/mm3)
Interferon alfa-2b (Intron A) Pregnancy category - Answer C
Interferon alfa-2b (Intron A) Onset - Answer 3 h (IM), immediate (IV)
Interferon alfa-2b (Intron A) Duration - Answer 2-3 h
Interferon alfa-2b (Intron A) Adverse Effects - Answer Flu-like syndrome of fever,
chills, dizziness, weight loss, and fatigue (occurs in at least 50% of patients)
Headache, nausea, vomiting, diarrhea, and anorexia
, Hair loss
Depression and suicidal ideation
Serious adverse effects (with prolonged therapy)
Immunosuppression
Hepatotoxicity
Neurotoxicity
Interferon alfa-2b (Intron A) Contraindications - Answer hypersensitivity to IFN
Autoimmune hepatitis or hepatic decompensation
Neonate or infant
Interferon alfa-2b (Intron A) Black box - Answer may cause or aggravate fatal or
life threatening neuropsychiatric, autoimmune, ischemic, or infectious disorders
Interferon alfa-2b (Intron A) Drug to drug interactions - Answer - use w/ ethanol may
cause excessive drowsiness/dehydration
- myelosuppression w/ antineoplastics
- zidovudine may increase hematologic toxicity
Interferon alfa-2b (Inton A) Lab test interactions - Answer - large decline in
hematocrit, leukocytes, platelets after 3-5 days of therapy
- elevated hepatic enzymes triglycerides
Interferon alfa-2b (Inton A) Treatment of overdose - Answer - causes lethargy/coma
- general supportive measures
Ibuprofen (Advil, Motrin) Therapeutic class - Answer analgesic, anti-inflammatory
drug, antipyretic
